- Home
- FDBC vs NVCT Comparison
FDBC vs NVCT Comparison
Compare FDBC & NVCT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | FDBC | NVCT |
|---|---|---|
| Founded | 1902 | 2020 |
| Country | US | US |
| Employees | N/A | N/A |
| Industry | Major Banks | Medicinal Chemicals and Botanical Products |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 255.2M | 220.0M |
| IPO Year | 2000 | 2021 |
Fundamental Metrics
Financial Performance| Metric | FDBC | NVCT |
|---|---|---|
| Price | $45.97 | $8.61 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 3 |
| Target Price | N/A | ★ $15.33 |
| AVG Volume (30 Days) | 3.9K | ★ 56.7K |
| Earning Date | 04-29-2026 | 05-13-2026 |
| Dividend Yield | ★ 3.81% | N/A |
| EPS Growth | ★ 12.85 | N/A |
| EPS | ★ 3.50 | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | $9.48 | ★ N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $37.00 | $5.55 |
| 52 Week High | $50.00 | $11.52 |
Technical Indicators
Market Signals| Indicator | FDBC | NVCT |
|---|---|---|
| Relative Strength Index (RSI) | 49.27 | 53.26 |
| Support Level | $44.69 | $8.47 |
| Resistance Level | $46.70 | $9.23 |
| Average True Range (ATR) | 1.48 | 0.51 |
| MACD | -0.08 | -0.02 |
| Stochastic Oscillator | 52.47 | 55.81 |
Price Performance
Historical ComparisonAbout FDBC Fidelity D & D Bancorp Inc.
Fidelity D & D Bancorp Inc is a bank holding company. Through its wholly-owned state-chartered commercial bank subsidiary, The Fidelity Deposit and Discount Bank (the Bank), it offers a full range of traditional banking services. The Bank has a personal and corporate trust department and also provides alternative financial and insurance products with asset management services. Its primary market areas are Lackawanna, Luzerne and Northampton Counties, Pennsylvania. The company's primary deposit products are demand deposits and interest-bearing time, money market and savings accounts. It offers a full array of loan products to meet the needs of retail and commercial customers. Company includes segments: Commercial and Industrial, Commercial Real Estate, Consumer, Residential Real Estate.
About NVCT Nuvectis Pharma Inc.
Nuvectis Pharma Inc is a biopharmaceutical company. The company is engaged in the development of innovative precision medicines for the treatment of serious conditions of unmet medical needs in oncology. It operates with one segment, focused on the development of novel targeted small molecule therapeutics for the treatment of cancer in genetically defined patient populations. Its pipeline products include NXP800, NXP900.